News Diamyd Medical AB

Equities

DMYD B

SE0005162880

Delayed Nasdaq Stockholm Other stock markets 06:59:34 2024-05-08 EDT			5-day change	1st Jan Change
10.56 ^SEK	+0.76%		-1.12%	+60.73%

04-18	Diamyd Medical Raises SEK57 Million in Rights Issue	MT
04-12	Recruitment Milestone Reaches in Diamyd® Phase 3 Trial	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Diamyd Medical Raises SEK57 Million in Rights Issue	04-18	MT
Diamyd Medical announces final outcome in the company's rights issue	04-18	AQ
Diamyd Medical announces preliminary outcome in the company's rights issue	04-16	AQ
Recruitment milestone reached in Diamyd® Phase 3 trial	04-12	AQ
Recruitment Milestone Reaches in Diamyd® Phase 3 Trial	04-12	CI
Diamyd Medical led ASSET innovation partnership organizes a workshop on the future treatment of Type 1 Diabetes	04-11	AQ
Diamyd Medical's main Shareholders announce their subscription commitments in the ongoing rights issue	04-05	AQ
Diamyd Medical publishes prospectus with regards to the rights issue	03-28	AQ
Quarterly Report II 23/24	03-27	AQ
Diamyd Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	03-27	CI
Diamyd Medical to Raise SEK114 Million Via Share Offering	03-19	MT
The Board of Directors in Diamyd Medical have resolved on a rights issue of approximately SEK 114 million	03-18	AQ
Diamyd Medical to present new genetic data at the ASIT summit in Boston, MA	02-29	AQ
Diamyd Medical to Present New Genetic Data at the ASIT Summit in Boston, MA	02-29	CI
Diamyd Medical Secures US FDA Fast Track Designation for Type 1 Diabetes Treatment	02-15	MT
Diamyd Medical receives U.S. FDA Fast Track designation for Diamyd®	02-15	AQ
Publication in Diabetologia highlights AI's potential for Type 1 Diabetes screening	02-14	AQ
In-depth analysis of Diamyd® Phase II trial further supports value of preserved insulin secretion	01-24	AQ
In-Depth Analysis of Diamyd Medical AB's Phase II Trial Further Supports Value of Presented Insulin Production	01-24	CI
Quarterly Report I 23/24	01-24	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Diamyd Medical AB

Equities

DMYD B

SE0005162880

Summary

Filters